2016
DOI: 10.1016/j.canrad.2015.07.155
|View full text |Cite
|
Sign up to set email alerts
|

Carcinome neuroendocrine à petites cellules des voies urinaires excrétrices supérieures : à propos d’un cas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…Osaka et al [10] reported a case of SCC of the ureter that was successfully treated by neoadjuvant cisplatin with irinotecan followed by nephroureterectomy with no recurrence or metastasis for 38 months postoperatively. Beddok et al [5] reported similar success with an 80-year-old male with SCC of the pelvic ureter with carboplatin and etoposide.…”
Section: Discussionmentioning
confidence: 80%
See 1 more Smart Citation
“…Osaka et al [10] reported a case of SCC of the ureter that was successfully treated by neoadjuvant cisplatin with irinotecan followed by nephroureterectomy with no recurrence or metastasis for 38 months postoperatively. Beddok et al [5] reported similar success with an 80-year-old male with SCC of the pelvic ureter with carboplatin and etoposide.…”
Section: Discussionmentioning
confidence: 80%
“…The incidence of EPSCC in North America is estimated to be between 0.1 and 0.4% [3]. EPSCC of the upper urinary tract, in particular, has had no more than 40 cases reported in the literature [4, 5]. The current knowledge of these rare tumors is limited, and treatment recommendations are mainly based on case reports, single-institution case series, or the extrapolation of results from pulmonary SCC [1, 3, 4, 5, 6, 7, 8].…”
Section: Introductionmentioning
confidence: 99%